Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Ae, Lichtin"'
Autor:
JN George, SH Woolf, GE Raskob, JS Wasser, LM Aledort, PJ Ballem, VS Blanchette, JB Bussel, DB Cines, JG Kelton, AE Lichtin, R McMillan, JA Okerbloom, DH Regan, I Warrier
Publikováno v:
Blood. 88:3-40
Autor:
Rt, Silver, Sh, Woolf, Hehlmann R, Fr, Appelbaum, Anderson J, Bennett C, Jm, Goldman, François Guilhot, Hm, Kantarjian, Ae, Lichtin, Talpaz M, Tura S
Publikováno v:
Europe PubMed Central
Because there are differing opinions regarding treatment of patients in the chronic phase of chronic myeloid leukemia (CML), the American Society of Hematology convened an expert panel to review and document evidence-based benefits and harms of treat
Autor:
Gurnari C; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Tor Vergata, Rome, Italy., Pagliuca S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Université de Paris, Paris, France., Patel BJ; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Awada H; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Kongkiatkamon S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Terkawi L; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Zawit M; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Corey S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Carraway HE; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Wahida A; Torsten-Haferlach Leukemia Diagnostics Foundation, Munich, Germany., Visconte V; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.
Publikováno v:
Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2431-2434. Date of Electronic Publication: 2021 Jan 22.
Autor:
Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Department of Biomedicine and Prevention, Phd in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kishtagari A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kerr CM; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Lichtin AE; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Cook JR; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org.
Publikováno v:
Leukemia [Leukemia] 2021 Jun; Vol. 35 (6), pp. 1792-1796. Date of Electronic Publication: 2021 Jan 07.
Autor:
Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy. Electronic address: carmelogurnari31@gmail.com., Graham AC; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Efanov A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; University Paris Diderot, Paris, France., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2021 Mar; Vol. 87, pp. 102528. Date of Electronic Publication: 2020 Dec 08.
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.
Autor:
Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Mahfouz RZ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kishtagari A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Jagadeesh D; Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hill BT; Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hamilton BK; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Carraway HE; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Nazha A; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Majhail NS; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sobecks R; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kalaycio M; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sekeres MA; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (2), pp. 318-322. Date of Electronic Publication: 2020 Jan 20.
Autor:
Kerr CM; Department of Translational Hematology and Oncology Research and., Clemente MJ; Department of Translational Hematology and Oncology Research and., Chomczynski PW; Department of Translational Hematology and Oncology Research and., Przychodzen B; Department of Translational Hematology and Oncology Research and., Nagata Y; Department of Translational Hematology and Oncology Research and., Adema V; Department of Translational Hematology and Oncology Research and., Visconte V; Department of Translational Hematology and Oncology Research and., Lichtin AE; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland; and., Radivoyevitch T; Quantitative Health Sciences Department, Cleveland Clinic, Cleveland, OH., Sekeres MA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Maciejewski JP; Department of Translational Hematology and Oncology Research and.; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Publikováno v:
Blood advances [Blood Adv] 2019 Mar 26; Vol. 3 (6), pp. 917-921.
Autor:
Rogers HJ; Medical Director of Hemostasis and Thrombosis, Hematopathologist, Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA. E-mail: rogersj5@ccf.org.; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Allen C; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic; Cleveland, OH, USA.; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Publikováno v:
Cleveland Clinic journal of medicine [Cleve Clin J Med] 2016 Aug; Vol. 83 (8), pp. 597-603.
Autor:
Kattoor AJ; Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Bauer TW; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA., Berkowitz M; Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, USA., Polster JM; Staff Radiologist, Imaging Institute, Cleveland Clinic, Cleveland, OH, USA.; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Lichtin AE; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA. E-mail: lichtia@ccf.org.
Publikováno v:
Cleveland Clinic journal of medicine [Cleve Clin J Med] 2015 Sep; Vol. 82 (9), pp. 607-13.
Autor:
Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic , Cleveland, OH , USA., Tabarroki A, Gerace CJ, Al-Issa K, Hsi ED, Rogers HJ, Sekeres MA, Silver BJ, Lichtin AE, Mukherjee S, Tiu RV
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2015 Jun; Vol. 56 (6), pp. 1888-90. Date of Electronic Publication: 2014 Nov 14.